Ordering sgrna synthesis: where chemical synthesis beats in vitro transcription for a guide, which modifications stop an immune response and extend half life, how purity grade changes editing efficiency, and what the certificate has to show

Specifying the guide

1. Choose chemical synthesis where modifications matter. Synthetic guides can carry modifications at defined positions, which is what raises stability and lowers the innate immune response in primary cells. For a guide that will go into cells that matter, this is usually the deciding factor rather than price.
2. Use transcription for scale and for length. In vitro transcription is cheaper per guide at volume and handles longer molecules easily, which suits screening libraries and early optimisation. The transcript carries a triphosphate end that can trigger an innate response, and treatment to remove it is worth specifying.
3. Specify the modifications by position, not by name. End modifications on the first and last few nucleotides are the common pattern and they materially raise editing in primary cells. Ask which positions are modified and with what, because the supplier's shorthand names differ.
4. Buy the purity grade the application needs. Truncated products from incomplete synthesis compete for the nuclease without cutting, so purification grade affects editing efficiency directly. Screening tolerates a lower grade; a single experiment in precious primary cells does not.
5. Check the certificate carries identity and purity. Mass spectrometry confirming the expected mass and a purity figure by a named method are the minimum. A concentration alone is a shipping note, and for a guide it tells you nothing about the fraction that is full length.

Delivery decides more than the guide does

A ribonucleoprotein complex delivered directly is transient and gives less off-target activity than a plasmid expressing the components for days. For primary cells and for therapeutic-adjacent work that transience is usually the point.

Match the guide format to the delivery: a complex needs purified protein and a synthetic guide, while a plasmid or viral route needs a cassette. Ordering the wrong format is a common and entirely avoidable delay.

Controls an editing experiment owes

A non-targeting guide, an untreated control and a measurement of editing at the intended site are the minimum. Reporting a phenotype without measuring editing at the locus is the commonest gap in this literature.

Where off-target activity matters, predicted sites should be sequenced at minimum and an unbiased method used where the stakes justify it. Prediction alone is a screen, not evidence.

Common questions

Synthetic or transcribed sgRNA?

Synthetic where modifications, defined ends and consistency matter, which covers most work in primary cells. Transcribed where cost per guide at scale matters, such as screening, accepting the triphosphate end and its innate immune consequences.

Do modifications really improve editing?

In primary cells and in vivo they make a substantial difference, by raising stability and reducing the innate response to a foreign RNA. In robust cell lines the difference is much smaller, which is why the answer depends on the destination.

What purity grade should I order?

The highest you can justify for experiments that matter, because truncated guides occupy the nuclease without cutting. For large screens a lower grade is the practical trade, and it should be a decision rather than a default.

What should the certificate show?

Identity by mass spectrometry against the expected mass, purity by a named method with a number, and concentration with the method used. Those three make the material traceable; a concentration alone does not.

Browse by service class

• Compare Gene synthesis on advertised prices